Previous Article | Next Article ![]()
Infection and Immunity, February 1999, p. 664-669, Vol. 67, No. 2
Infectious Disease Division,
Winthrop-University Hospital, Mineola, New York
11501,1 and
Department of Microbiology,
University of Barcelona, Microbiología, Diagonal 645, Barcelona, Spain 080712
Received 30 July 1998/Returned for modification 23 September
1998/Accepted 17 November 1998
The bacterial capsule is an important virulence determinant in
animal and plant disease. Bacterial capsule and slime can be inhibited
by bismuth compounds, especially when complexed with lipophilic thiol
chelators. Bismuth dimercaprol (BisBAL) at 1 ppm of Bi3+
repressed Klebsiella pneumoniae capsule expression in
defined medium by nearly 90%, which exposed subsurface structures. The phagocytic index for BisBAL-treated bacteria increased from <10 to 360 bacteria per 100 neutrophils in the presence of complement and
anticapsular or anti-O antigen antiserum. BisBAL treatment also
enhanced the reactivity of monoclonal antibodies (MAbs) specific for
the O1-antigen lipopolysaccharide (LPS) or the LPS core in a
dose-dependent manner as indicated by the results of enzyme-linked immunosorbent assays. When anti-O1 MAb was used, the reactivity increased significantly for fully encapsulated O1:K1 or O1:K2 cells but
not for O1:K
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Surface Antigen Exposure by Bismuth Dimercaprol
Suppression of Klebsiella pneumoniae Capsular
Polysaccharide
cells. Deposition of C3b also increased
significantly for BisBAL-treated O1:K1 or O1:K2 cells but not for
O1:K
cells. Survival of a serum-sensitive
strain was <0.1% when nonimmune human serum absorbed with O1:K1 cells
was used and 107% when BisBAL-treated cells were used for
absorption. Outer membrane proteins were also more accessible on
the surface of K. pneumoniae after BisBAL
treatment. Thus, at subinhibitory levels, BisBAL inhibited capsule
expression, which promoted phagocytosis, enhanced the
reactivity of specific antibodies for LPS O antigen, LPS core
epitopes, or outer-membrane proteins, and enhanced complement
interaction with encapsulated K. pneumoniae. By unmasking bacterial surface structures and
enhancing the immune system reactivity to bacteria, bismuth
thiols may prove useful as adjuncts for vaccination.
*
Corresponding author. Mailing address: Infectious
Disease Division, Winthrop-University Hospital, 259 First St., Mineola, NY 11501. Phone: (516) 663-2654. Fax: (516) 663-3886. E-mail: domenico{at}winthrop.org.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»